The Effects of Vasopressin on Attention Control

• Status: Completed
• Trial end date: 2021-01-01
• Target enrollment: 0
• Participant gender: Male

Summary

The main aim of the present study is to investigate whether intranasal vasopressin (20IU) could influence attention control in a social-emotional saccade/antisaccade eye-tracking paradigm.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Electronic Science and Technology of China
• Treatments: Arginine Vasopressin; Vasopressins

Criteria

Inclusion Criteria:

• Healthy participants

• Non smokers

Exclusion Criteria:

• Previous or current medical, psychiatric, neurological disorder

• Regular medication

• Use of any psychoactive substances in the 24 hours before experiment

• Contra-indications for vasopressin

• Contra-indications for eye-tracking data acquisition